Financial Planner's morning report - Wednesday
Despite an increasing chorus of experts suggesting the technology sector has moved beyond reasonable levels, the rally continues. The ASX 200 (ASX:XJO) added...
Financial Planner's morning report - Tuesday
The ASX 200 (ASX:XJO) continued its recent weakness, falling 0.5% on Monday, as concerns of a secondary outbreak in NSW and escalating deaths in the US hit...
Financial Planner's morning report - Monday
Sideways….a weak opening ahead It was another bumpy, albeit positive, week for markets with the ASX 200 (ASX:XJO) gaining 0.4% on Friday and finishing...
Financial Planner's morning report - Monday
Sideways….a weak opening ahead It was another bumpy, albeit positive, week for markets with the ASX 200 (ASX:XJO) gaining 0.4% on Friday and finishing...
ASX 200 expected to rise, 5 ASX shares to watch
Wednesday proved to be another wild day for markets with Australia's ASX 200 index down over 1% at the open, only to rally 2% and finally finish 5 points down...
Financial Planning morning report - Wednesday
The ASX 200 experienced its best day in over seven weeks on Tuesday, adding 2.9% to 5,780 points, with all sectors increasing. The Australian share market has...
Financial planner daily report - ASX shares to rise at the open
In the USA, it was Memorial Day. However, a strong lead from the local futures market was enough to send the ASX 200 to an 11-week high on Monday, but over 2%...
Financial planner morning report - Monday
It was another strong week for global markets with the ASX 200 rising 1.7% and the Dow Jones ending up 3.3% last week, as reporting season continued.
Financial Planner morning report Friday
It seems to me that global markets are stuck in a trading pattern, oscillating between euphoria when signs of a vaccine are announced, to despair as new...
Financial Planner morning report - Thursday
Here's the Financial Planning news you need to know. Overnight, global share markets recovered on the back of an improving crude oil price, now $32 per barrel,...
Financial Planner morning report Tuesday
A covid cure on the horizon? US-based drugmaker Moderna revealed positive results from its human trials of a Coronavirus vaccine, treating those yet to suffer...